Published ECCO Guidelines
In its aim to foster transparency, ECCO has diligently maintained a disclosure policy of potential conflicts of interests (CoI) for several years: ECCO Guidelines manuscripts cannot be submitted for publication without all authors having submitted their CoI Forms.
As ECCO experts are increasingly involved in several activities such as the ECCO Congress, Workshops, Guidelines, or other projects, including publications of papers in JCC (Journal of Crohn’s & Colitis) throughout one year, ECCO now collects one completed CoI form from experts in line with the respective Congress business year (updated every autumn). These forms are publically accessible through the ECCO website – showing the “ECCO Annual Disclosure of potential conflicts of interest”.
This is the first European Crohn’s and Colitis Organisation [ECCO] consensus guideline that addresses extra-intestinal manifestations [EIMs] in inflammatory bowel disease [IBD]. It has been drafted by 21 ECCO members from 13 European countries. Although this is the first ECCO consensus guideline that primarily addresses EIMs, it is partly derived from, updates, and replaces previous ECCO consensus advice on EIMs, contained within the consensus guidelines for Crohn’s disease1 [CD] and ulcerative colitis2 [UC].
Due to the important clinical problem that the risk of malignancy in patients with IBD represents for physicians treating IBD, ECCO planned to initiate a programme to develop a specific Guideline for malignancy.
The aim of this consensus is to establish Guidelines for managing the risk of malignancy, treatment in the event of malignancy and therapy of IBD in the context of a past or current history of malignancy
The aim of this consensus is establish up-to-date standards for the diagnosis, follow-up and management of anemia in IBD patients with a special focus on iron deficiency anemia in IBD.
The ECCO Consensus guidelines on the diagnosis and management of IBD are regularly updated. This updated consensus paper addresses these issues and is aimed to optimize preconceptional counseling in patients with inflammatory bowel disease and to promote a European perspective on the management of pregnancy in patients with IBD and its dilemmas.
The goal of this consensus was to establish European consensus guidelines for the surgical treatment of Ulcerative Colitis.
The aim of this consensus is to establish standards for the management of Pediatric CD. All treatment aspects will be considered, induction as well as maintenance therapy, nutritional treatment approaches as well as the use of anti-inflammatory drugs, immunosuppressors, or biologics.
The aim of this new consensus is to establish standards for the diagnosis and management of Paediatric UC. It will include the use of immunosuppressors and biologics.
The aim of this new consensus is to establish standards for the diagnosis, follow-up and surveillance in IBD, including the differential diagnosis of other colitides.
The aim of this new consensus is to establish standards for diagnosis and pathological procedures in IBD and other colitides, such as lymphocytic and collagenous Colitis and variants, indeterminate, unclassified Colitis and infectious Colitis related to IBD.
N-ECCO Consensus statements on the European nursing roles in caring for patients with CD or UC (2013)
The N-ECCO Consensus provides clarity on the different nursing roles in caring for patients with Crohn’s disease and ulcerative colitis within Europe. The intention is to identify the position of IBD nurses and provide a consensus on the ideal standard of nursing care that patients with IBD can expect, irrespective of level of training or title.
The ECCO-ESGAR Consensus on Imaging techniques for assessment of IBD establishes standards for the use of cross-sectional imaging techniques in IBD. Imaging will include MRI, CT and US but not endoscopy or capsule endoscopy, even though these investigations will be at the background of all discussions.
The aim of this consensus is to establish standards for the management of paediatric Acute Severe Ulcerative Colitis.